AstraZeneca and Columbia University Medical Center Form Collaboration
Posted on: Thursday, 16 October 2008, 12:00 CDT
AstraZeneca and Columbia University Medical Center have announced a new research collaboration to examine how neurogenesis - the creation of new neuronal cells - in adults might offer novel approaches to treating depression and anxiety.
This new alliance with Columbia University Medical Center is one of several new alliances by AstraZeneca with academic and research institutions to address unmet medical needs through research across several disease areas, including Alzheimer's disease, chronic pain and psychiatric illnesses.
These proposed new agreements complement existing AstraZeneca alliances in neuroscience and other key therapeutic areas with institutions like Columbia. AstraZeneca & Columbia University Medical Center have previously announced strategic research collaboration in the area of metabolic disease.
Jeffrey Lieberman, chairman of Columbia's department of psychiatry, said: "This collaboration is one example of a partnership aimed at new approaches to better treatment options in psychiatry. Medication therapy is part of a comprehensive treatment plan for those with mental illness and truly innovative, science-based, targeted therapies are desperately needed for those who are still today one of our most vulnerable patient populations."
Source: Datamonitor
Related Articles
- U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold
- Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
- U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'RESUS' Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
- Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
- U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting
- Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials; Trials to Be Conducted With Mary Crowley Medical Research Centers
- The Urban Water Research Center at the University of California Irvine and Makar Properties Present ``The Looming Crisis in Water''
- Accelr8 Announces Research Programs in Two Leading Medical Research Centers
- Sidra Medical & Research Center's Sparkling Design Incorporates Nature to Promote Healing
- Biosphere Development Corp., A Subsidiary of Global Environmental Energy Corp (OTCBB: GEECF); Invited to Discuss Opening Environmental Research Center at the University of Shaoxing
 |
 |
User Comments (0)
RSS Feeds